Sunitinib

Educational summary, not a formulary. Dosing is quoted from the Makindo chapters and topics site. The other sections are draft summaries not yet checked line by line against the BNF or SPC. Check dose, indication, interactions and monitoring in the BNF entry for Sunitinib and local guidelines before prescribing.

Tyrosine kinase inhibitor

Mechanism

Multi-targeted tyrosine kinase inhibitor.

Uses

Renal cell carcinoma, GIST, pancreatic neuroendocrine tumours.

Dosing

No dose is given in the chapters. See the BNF.

Side effects

Hypertension, hypothyroidism, hand-foot syndrome, fatigue, diarrhoea, cardiac dysfunction.

Interactions

CYP3A4 inhibitors and inducers.

Contraindications and cautions

Pregnancy

Monitoring

BP, TFT, LVEF

Pregnancy and breastfeeding

Contraindicated

Renal and hepatic impairment

Caution in severe hepatic impairment

Overdose and reversal

Supportive

Special advice

Check BP and TFT; 4-weeks-on 2-weeks-off schedule.

More from the textbook: uses, cautions and other points
Where it is discussed in the book